News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 910
- Sources here
- 20
- Companies here
- 16
Search results
Stored financial headlines
Active search
910 matching headlines
Ticker or company: MARIMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Maris Tech Ltd (MTEK) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Maris Tech Ltd (MTEK), detailing future estimates for EPS and revenue growth. It presents an overview of the company's stock performance, key financial metrics like market cap and P/E ratio, and allows users to track its forecast …
MTEK
main company
Sharemaestro market context
New activity signal
52 weeks -48.8%
Navios Maritime Partners Number of Employees 2026 | Employee Count & Headcount Data
Navios Maritime Partners LP (NMM) has a global workforce of 658 employees as of March 2026, marking a 29.0% growth from 2023. The company, headquartered in Dimos Piraeus, Greece, is not actively hiring despite its workforce growth, and its employees are primarily concentrated in …
NMM
main company
Sharemaestro market context
Trend signal active
52 weeks +75.4% · Next-week setup positive 58.9%
Globus Maritime Ltd (GLBS) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Globus Maritime Ltd (GLBS), indicating an earnings forecast score of 8.00 and a 'Buy' analyst rating from one analyst. The expected revenue for the next quarter is $13.90 million, with a price target of $3.00. The article …
GLBS
main company
Sharemaestro market context
Trend signal active
52 weeks +259.0%
MarineMax | 8-K: Current report
This article is a brief notification regarding MarineMax's 8-K filing, which is a Current Report. The content indicates that the filing itself constitutes the complete document.
HZO
main company
Sharemaestro market context
Trend signal active
52 weeks +85.3% · Next-week setup negative 41.2%
Bank of Marin Bancorp To Go Ex-Dividend On August 6th, 2026 With 0.25 USD Dividend Per Share
Bank of Marin Bancorp (NASDAQ:BMRC) is scheduled to go ex-dividend on August 6th, 2026, with a dividend payment of $0.25 per share. Shareholders who own BMRC stock before this date will be eligible for the dividend. The ex-dividend date is crucial for investors as …
BMRC
main company
Sharemaestro market context
Trend signal active
52 weeks +20.0%
Bank of Marin Bancorp Q2 2026: Revenue $30.8M, EPS $0.58— 10-Q Summary
Bank of Marin Bancorp (BMRC) reported its Q2 2026 results, showing a significant turnaround with net income of $9.25 million and diluted EPS of $0.58, compared to a loss in the prior year. This improvement was driven by higher net interest income, improved net …
BMRC
main company
Sharemaestro market context
Trend signal active
52 weeks +20.0%
Biomarin Pharma earnings beat by $0.25, revenue topped estimates
Biomarin Pharma (NASDAQ: BMRN) reported strong second-quarter results, beating analyst estimates for both earnings per share (EPS) and revenue. The company posted an EPS of $1.20, exceeding the $0.95 consensus, and revenue of $990 million, higher than the $939.37 million estimate. Its stock has …
BMRN
main company
Sharemaestro market context
Trend signal active
52 weeks +15.0%
Bank of Marin FY26 Q2 net income rises 8.65% to USD 9.25 million; diluted EPS climbs to USD 0.58
Bank of Marin Bancorp reported an 8.65% increase in GAAP net income to $9.25 million for FY26 Q2, with diluted EPS rising to $0.58. The bank saw a 1.58% rise in net interest income and a 14 basis point widening of its tax-equivalent net …
BMRC
main company
Sharemaestro market context
Trend signal active
52 weeks +20.0%
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q2 revenue up, profit down after Amicus acquisition
BioMarin Pharmaceutical Inc. reported a significant increase in Q2 2026 total revenues to $989.7 million, up from $825.4 million in 2025, primarily due to strong performance from VOXZOGO, PALYNZIQ, and newly acquired products GALAFOLD and POMBILITI + OPFOLDA. Despite revenue growth, net income fell …
BMRN
main company
Sharemaestro market context
Trend signal active
52 weeks +15.0%
SHIP (SHIP) insider plans 15,000-share stock sale via Morgan Stanley
A Form 144 filing indicates that a holder of Seanergy Maritime Holdings Corp. (SHIP) plans to sell 15,000 common shares through Morgan Stanley Smith Barney LLC. The shares, valued at $257,890.50, were acquired on October 24, 2023, as restricted stock vesting for services rendered. …
SHIP
main company
Sharemaestro market context
Trend signal active
52 weeks +122.7% · Next-week setup positive 56.4%
Seanergy Maritime (NASDAQ: SHIP) posts record Q2 profit and boosts dividend
Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) reported record Q2 2026 net income of $26.2 million and EPS of $1.21, significantly up from the prior year, and boosted its quarterly dividend to $0.35 per share, marking its 19th consecutive distribution. The company is actively pursuing …
SHIP
main company
Sharemaestro market context
Trend signal active
52 weeks +122.7% · Next-week setup positive 56.4%
Earnings Flash (BMRN) BioMarin Pharmaceutical Inc. Posts Q2 Adjusted EPS $1.20 per Share, vs. FactSet Est of $0.95
BioMarin Pharmaceutical Inc. (BMRN) reported Q2 adjusted EPS of $1.20 per share, surpassing the FactSet estimate of $0.95. The company also announced Q2 revenue of $990.0 million, exceeding the FactSet estimate of $932.0 million, and provided updated earnings guidance for the full year 2026. …
BMRN
main company
Sharemaestro market context
Trend signal active
52 weeks +15.0%
BioMarin earnings on deck as flagship drug faces competition
BioMarin Pharmaceutical Inc. is set to report second-quarter earnings, with analysts expecting 95 cents per share on $939.2 million in revenue, an increase from the previous quarter. The upcoming earnings call will likely focus on the competitive landscape for its top drug, VOXZOGO, which …
BMRN
main company
Sharemaestro market context
Trend signal active
52 weeks +15.0%
BioMarin Pharmaceutical Q2 Earnings Call Highlights
BioMarin Pharmaceutical's Q2 revenue approached $1 billion, a 20% increase year-over-year, driven by its rare-disease portfolio and the Amicus acquisition. The company raised its full-year guidance for revenue, VOXZOGO revenue, and non-GAAP EPS, projecting significant growth from Amicus therapies and VOXZOGO becoming a $1 …
BMRN
main company
Sharemaestro market context
Trend signal active
52 weeks +15.0%
Martin Marietta Materials Inc. stock underperforms Thursday when compared to competitors
Shares of Martin Marietta Materials Inc. (MLM) fell 2.73% to $538.28 on Thursday, marking its second consecutive day of losses. This underperformance occurred during a generally dismal trading session, with the S&P 500 Index and Dow Jones Industrial Average also experiencing declines.
MLM
main company
Sharemaestro market context
Price below Trend Line
52 weeks -9.4%
MarineMax, Inc. Just Beat Revenue Estimates By 5.2%
MarineMax, Inc. (NYSE:HZO) exceeded revenue estimates by 5.2%, reporting US$758m, and statutory earnings per share (EPS) of US$1.37, which was 2.8% above expectations. Analysts have increased their EPS forecasts for 2025 by 46% to US$3.23 and raised the consensus price target by 29% to …
HZO
main company
Sharemaestro market context
Trend signal active
52 weeks +85.3% · Next-week setup negative 41.2%
EQS-News: Benzinga: Seanergy Maritime And United Maritime Report Q2 Results, Continue Dividend Track Records
Seanergy Maritime Holdings Corp. and its spin-off, United Maritime Corp., both reported their Q2 2026 financial results, highlighting strong performance and continued dividend distributions. Seanergy achieved record revenue, net income, and EBITDA, declaring its 19th consecutive quarterly dividend. United Maritime also maintained its dividend …
USEA
main company
Sharemaestro market context
Trend signal active
52 weeks +88.8% · Next-week setup positive 56.7%
Dimensional Fund Advisors LP Cuts Stock Position in MarineMax, Inc. $HZO
Dimensional Fund Advisors LP reduced its stake in MarineMax, Inc. (NYSE:HZO) by 7.5% in the first quarter, selling over 78,000 shares but retaining a significant holding worth approximately $26.2 million. Other institutional investors also adjusted their positions in the company, which is 92.85% owned …
HZO
main company
Sharemaestro market context
Trend signal active
52 weeks +85.3% · Next-week setup negative 41.2%